{"id":3028,"date":"2016-07-14T21:52:24","date_gmt":"2016-07-14T21:52:24","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=16162"},"modified":"2016-07-14T21:52:24","modified_gmt":"2016-07-14T21:52:24","slug":"kannalife-sciences-founder-ceo-speak-sports-illustrated-concussions-nfl","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/07\/14\/kannalife-sciences-founder-ceo-speak-sports-illustrated-concussions-nfl\/","title":{"rendered":"Kannalife\u2122 Sciences Founder and CEO Speak with Sports Illustrated about Concussions and the NFL"},"content":{"rendered":"
What would it take for Kannalife\u2122 Sciences to work with the NFL to put a stop to the out of control rate of concussions and <\/span>chronic traumatic encephalopathy<\/span><\/a> (CTE) in the league? <\/span><\/p>\n \u201cA phone call. That\u2019s it,\u201d says Dean Petkanas, CEO of Kannalife\u2122 Sciences in a recent profile by Sports Illustrated.<\/span><\/p>\n Despite numerous calls by <\/span>former<\/span><\/a> and <\/span>current players<\/span><\/a> to adopt a new policy on medical marijuana use in the NFL, the league has remained stubbornly stuck to their ways in the face of a <\/span>96% rate<\/span><\/a> of CTE among players.<\/span><\/p>\n Kannalife\u2122 Sciences sees another way to go about it. The company holds a license to develop cannabinoid-based pharmaceutical treatments for CTE under the National Institutes of Health patent #6,630,507, \u201cCannabinoids as antioxidants and neuroprotectants\u201d.<\/span><\/p>\n Petkanas and Kannalife\u2122 founder Thoma Kikis <\/span>spoke with<\/span><\/a> Sports Illustrated\u2019s Ben Baskin about ways their company intends to use the NIH\u2019s patent to help prevent and treat what has become the primary concern of the NFL and its players in recent years. <\/span><\/p>\n \u201cWe\u2019re thankful that this leading sports website is bringing light and awareness to how Cannabis, including both THC and CBD, could be a leading therapeutic approach for treating and preventing brain injuries that plague a high percentage of current and retired NFL football players and all athletes participating in concussion-related sports,\u201d said Dr. Stuart Titus, CEO of Medical Marijuana, Inc., which is invested in Kannalife\u2122 Sciences.<\/span><\/p>\n Kannalife\u2122 Sciences is a biomedical research company dedicated to the use of the \u2018507 patent to develop novel treatments for neurological diseases. When Petkanas and Kikis resolved to enter the cannabis industry, they decided to go the pharmaceutical route where they would be able to make most significant change. <\/span><\/p>\n Petkanas, after four months of researching, discovered <\/span>hepatic encephalopathy<\/span><\/a> (HE) as a potential target for their efforts. When he took it to Kikis, Petkanas had no idea that Kikis\u2019s father had been diagnosed with HE or that Kikis had spent time with his father in the hospital due to the illness just the week before.<\/span><\/p>\n Kannalife\u2122 Sciences went to work studying the effects of cannabinoids, focusing on non-psychoactive <\/span>cannabidiol<\/span><\/a> (CBD). At first, the company placed their effort into HE, for which they have an exclusive license on the \u2018507 patent. However, they soon realized that CBD could be effective for a number of neurodegenerative diseases, including CTE. <\/span><\/p>\n \u201cWe know that CBD is neuroprotective,\u201d Kinney says. \u201cWe have seen effects in both protecting against cell death and increasing cell viability\u2026 We think CBD could protect the neurons from future injury and also help them repair.\u201d<\/p>\n In simpler terms, CBD is capable of defending brain cells during trauma. By 2014, Kannalife\u2122 Sciences had secured a license to develop a treatment for CTE as well.<\/span><\/p>\n The development of a CBD-based pharmaceutical to prevent and treat CTE should be big news for the NFL.<\/span><\/p>\n \u201cCBD has an amazing amount of potential,\u201d says Dr. Bill Kinney, the chief scientific officer of Kannalife\u2122 Sciences. \u201cThink about this: What if a football player could just take a pill that is non-psychoactive before the game and now have a greater level of protection against brain injury? What could be better than that?\u201d<\/span><\/p>\n Kannalife\u2122\u2019s laboratories are located in the Pennsylvania Biotechnology Center in Doylestown, Pa., a shared space where their researchers are working to develop CBD into pharmaceuticals. Kannalife\u2122 Sciences has partnered with Dr. Ron Tuma and Dr. Sara Jane Ward, professors at Temple University who have been researching CBD as a neuroprotective agent for years. <\/span><\/p>\n \u201cWith CTE, and other injuries to the central nervous system, inflammation plays a very important role in exacerbating the injury,\u201d Tuma says. \u201cSo it\u2019s the interaction of cannabinoids with the inflammatory process that gives us the hope that it will have therapeutic benefit.\u201d<\/span><\/p>\n The team has developed a synthetic form of CBD that they hope will benefit athletes competing in contact sports and others who have suffered concussions. The new compound, KLS-13019, is up to 500 times safer and 50 times more potent than naturally occurring CBD, and the body is 10 times more able to absorb the compound.<\/span><\/p>\n \u201cImagine if you had a molecule that is structurally different than CBD, so it\u2019s not a controlled substance, but still has that same benefit of neuroprotection,\u201d Kinney says. \u201cThat is something the NFL could wrap its arms around.\u201d<\/span><\/p>\n Kannalife\u2122 Sciences approached the NFL years back with an information packet presenting the benefits cannabinoids could offer the league, including its efficacy, non-psychoactivity and no potential for abuse, and ability to pass NFL drug testing restrictions. However, Petkanas and Kikis never heard back. <\/span><\/p>\n For now the company continues to push on pursuing its development of a treatment for CTE. With up to <\/span>3.8 million<\/span><\/a> sports-related concussions in the U.S. annually and the rate of brain injury among children <\/span>doubled<\/span><\/a>, there is a distinct need to protect the brains of athletes. However, there is also a need for CTE treatments outside of athletics. The military saw an estimated <\/span>300,000 cases<\/span><\/a> of traumatic brain injury from 2001 to 2010, and as a total population, there were <\/span>2.5 million<\/span><\/a> hospital visits for traumatic brain injury in the U.S. in 2010. <\/span><\/p>\n Medical Marijuana, Inc. has supported CTE research and awareness in the past when it started the <\/span>Show Your Green<\/span><\/a> and <\/span>Treat CTE<\/span><\/a> campaigns in late 2015. Marvin Washington, Kannalife\u2122 spokesperson and former NFL player, joined a panel on ESPN\u2019s Outside the Lines where he discussed the significance of CTE for NFL players and urged the NFL to contact him or Kannalife\u2122 Sciences to work together to end the high rates of CTE in NFL players. <\/span><\/p>\n To learn more about <\/span>chronic traumatic encephalopathy<\/span><\/a>, visit the Medical Marijuana, Inc. <\/span>education page<\/span><\/a>. <\/span> \t<\/p>\n","protected":false},"excerpt":{"rendered":" Dean Petkanas and Thoma Kikis discuss the potential role cannabidiol (CBD) can play in the protection and treatment of NFL players from brain injury. What would it take for Kannalife\u2122 Sciences to work with the NFL to put a stop to the out of control rate of concussions and chronic traumatic encephalopathy (CTE) in the […]<\/p>\n","protected":false},"author":1,"featured_media":3029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,163,162],"tags":[179],"class_list":["post-3028","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-kannalife-sciences","category-media-coverage","tag-kannalife-sciences"],"yoast_head":"\n